Communicable disease threats report, 7-13 June 2020, week 24
This issue of the CDTR (Communicable Disease Threats Report) covers the period from 7-13 June 2020 and includes updates on COVID-19, Crimean-Congo haemorrhagic fever, Ebola and West Nile fever.
Communicable disease threats report, 24-30 May 2020, week 22
This issue of the CDTR (Communicable Disease Threats Report) covers the period from 24-30 May 2020 and includes updates on COVID-19, Ebola fever and influenza.
The 2019 report of The Lancet Countdown on health and climate change: ensuring that the health of a child born today is not defined by a changing climate
Watts, N., Amann, M., Arnell, N., Ayeb-Karlsson, S., Belesova, K., Boykoff, M., Byass, P., Cai, W., Campbell-Lendrum, D., Capstick, S., Chambers, J., Dalin, C., Daly, M., Dasandi, N., Davies, M., Drummond, P., Dubrow, R., Ebi, K.L., Eckelman, M., Ekins, P., Escobar, L.E., Fernandez Montoya, L., Georgeson, L., Graham, H., Haggar, P., Hamilton, I., Hartinger, S., Hess, J., Kelman, I., Kiesewetter, G., Kjellstrom, T., Kniveton, D., Lemke, B., Liu, Y., Lott, M., Lowe, R., Sewe, M.O., Martinez-Urtaza, J., Maslin, M., McAllister, L., McGushin, A., Jankin Mikhaylov, S., Milner, J., Moradi-Lakeh, M., Morrissey, K., Murray, K., Munzert, S., Nilsson, M., Neville, T., Oreszczyn, T., Owfi, F., Pearman, O., Pencheon, D., Phung, D., Pye, S., Quinn, R., Rabbaniha, M., Robinson, E., Rocklöv, J., Semenza, J.C., Sherman, J., Shumake-Guillemot, J., Tabatabaei, M., Taylor, J., Trinanes, J., Wilkinson, P., Costello, A., Gong, P., Montgomery, H.
Communicable disease threats report, 24-30 June 2018, week 26
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 June 2018, and includes updates on Vibrio growth in the Baltic sea, polio, Ebola virus disease, West Nile Virus, and mass gathering monitoring – FIFA World Cup 2018.
ECDC: first detected cases of extensively drug-resistant gonorrhoea threaten future treatment
Within a matter of weeks, three cases of gonorrhoea that are resistant to the recommended first line antibiotic treatment have been detected in Europe and Australia. These are the first global reports of Neisseria gonorrhoeae with high-level resistance to azithromycin and ceftriaxone resistance that also show resistance to several other vital antibiotics. At a time with limited alternatives to the current dual therapy, lack of a vaccine and insufficient surveillance capacity in some regions, these cases highlight the growing threat of drug-resistance – which could lead to untreatable gonorrhoea.
Rapid Risk Assessment: Extensively drug-resistant (XDR) Neisseria gonorrhoeae in the United Kingdom and Australia
This rapid risk assessment aims to assess the risk of XDR Neisseria gonorrhoeae spreading further in the EU/EEA and provide some options for response.
Communicable disease threats report, 23 July - 29 July, week 30
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23 July - 29 July 2017 and includes updates on measles, seasonal influenza, West Nile fever, legionnaires' disease and chikungunya, dengue and Zika viruses.
Rapid risk assessment: Zika virus disease epidemic. 10th update, 4 April 2017
This is an updated assessment of the risks associated with the Zika virus epidemic in affected countries, EU Overseas Countries and Territories, and Outermost Regions and in EU Member States within continental Europe.
Oseltamivir-resistant influenza A(H1N1)pdm09 patterns across the globe: findings in Australia (season 2011) and United States (season 2010-11)Archived
In this letter the authors describe being able to identified a sustained community transmission of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Australia
Rapid risk assessment: Oseltamivir-resistant influenza A(H1N1)2009 cluster in Australia
Australia has reported a cluster of oseltamivir-resistant influenza A(H1N1)2009 cases in the state of New South Wales. The cases had no known link to oseltamivir exposure and individuals were not immunosuppressed, but they were closely linked geographically. Samples from the cluster do not currently exhibit any resistance to zanamivir.